semaglutide bone density New studies have raised fresh alarms about the popular “weight-loss drug” Ozempic, revealing it may accelerate loss and weaken skeletal health in users. Research published in 2025–2026 shows patients on CT shows body composition changes

ASC30, a once-monthly SQ injected small molecule GLP-1RA in participants with obesity: a Ph Ib study [Poster]

Summary: Ozempic (semaglutide) commonly causes nausea and gastrointestinal symptoms, particularly during initial treatment and dose increases, though these effects typically lessen over time as the body adapts

Also broader effects on gene expression beyond just antioxidants

Cold-Chain Storage and Shipping: Retatrutide is highly sensitive to temperature and light

The GST-tag is often used to increase the yield of expression and solubility of the target protein, however, removal of the Fig 1

At Elon Health Urgent Care in Davenport, FL, our team can help determine what is behind your symptoms